Collegium Pharmaceutical
COLL
COLL
227 hedge funds and large institutions have $1.54B invested in Collegium Pharmaceutical in 2024 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 78 increasing their positions, 78 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
227
Holders Change
+34
Holders Change %
+17.62%
% of All Funds
3.29%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
51
Increased
78
Reduced
78
Closed
16
Calls
$3.33M
Puts
$601K
Net Calls
+$2.73M
Net Calls Change
+$4.57M
Top Buyers
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$37.6M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$16M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$9.66M |
| 4 |
Man Group
London,
United Kingdom
|
+$7.96M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$7.38M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$45.3M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$35.9M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$10.7M |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$10.6M |
| 5 |
Millennium Management
New York
|
-$9.72M |
